MX2009005445A - Sistema de suministro para risperidona. - Google Patents

Sistema de suministro para risperidona.

Info

Publication number
MX2009005445A
MX2009005445A MX2009005445A MX2009005445A MX2009005445A MX 2009005445 A MX2009005445 A MX 2009005445A MX 2009005445 A MX2009005445 A MX 2009005445A MX 2009005445 A MX2009005445 A MX 2009005445A MX 2009005445 A MX2009005445 A MX 2009005445A
Authority
MX
Mexico
Prior art keywords
risperidone
delivery system
polymer
formulation
skin
Prior art date
Application number
MX2009005445A
Other languages
English (en)
Inventor
Wouter De Graaff
Armin Szegedi
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of MX2009005445A publication Critical patent/MX2009005445A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Está invención se refiere a una formulación de liberación prolongada que contiene risperidona sólida, cuya formulación en un dispositivo vaginal que tiene una piel y cuyo dispositivo comprende un compartimiento interior elaborado de un polímero termoplástico, cuyo polímero contiene risperidona. El polímero preferiblemente está elaborado de copolímero de etileno y acetato de vinilo.
MX2009005445A 2006-11-22 2007-11-21 Sistema de suministro para risperidona. MX2009005445A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06124598 2006-11-22
PCT/EP2007/062628 WO2008062009A1 (en) 2006-11-22 2007-11-21 Delivery system for risperidone

Publications (1)

Publication Number Publication Date
MX2009005445A true MX2009005445A (es) 2009-06-02

Family

ID=37898528

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2009005444A MX2009005444A (es) 2006-11-22 2007-11-21 Sistema de suministro para un farmaco hidrofilico no esteroide no ionizado.
MX2009005445A MX2009005445A (es) 2006-11-22 2007-11-21 Sistema de suministro para risperidona.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2009005444A MX2009005444A (es) 2006-11-22 2007-11-21 Sistema de suministro para un farmaco hidrofilico no esteroide no ionizado.

Country Status (6)

Country Link
US (2) US20100203104A1 (es)
EP (2) EP2094270A1 (es)
JP (2) JP2010510286A (es)
CA (2) CA2670157A1 (es)
MX (2) MX2009005444A (es)
WO (2) WO2008062008A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
US7858110B2 (en) * 2003-08-11 2010-12-28 Endo Pharmaceuticals Solutions, Inc. Long term drug delivery devices with polyurethane based polymers and their manufacture
CA2437639C (en) 2003-08-11 2016-07-05 Valera Pharmaceuticals, Inc. Long term drug delivery devices with polyurethane based polymers and their manufacture
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) * 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
MX2009000053A (es) * 2006-07-12 2009-02-23 Controlled Therapeutics Sct Polimero para el suministro de medicamentos con sal clorhidrato de clindamicina.
GB0620685D0 (en) 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
WO2008062008A1 (en) * 2006-11-22 2008-05-29 N.V. Organon Delivery system for a non-steroidal non-ionized hydrophilic drug
WO2009129459A1 (en) * 2008-04-18 2009-10-22 Combinent Biomedical Systems, Inc. Devices that include ethylene-vinyl acetate copolymers and methods of making and using same
US9078900B2 (en) * 2008-09-30 2015-07-14 Braeburn Pharmaceuticals Bvba Sprl Implantable device for the delivery of risperidone and methods of use thereof
CA2792179C (en) 2010-03-16 2019-04-02 Titan Pharmaceuticals, Inc. Heterogeneous implantable devices for drug delivery
US20170319833A1 (en) * 2010-03-28 2017-11-09 Evestra, Inc. Intravaginal drug delivery device
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
DE102013011399A1 (de) 2012-07-31 2014-02-06 Amw Gmbh Implantat mit Risperidon
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
US10406336B2 (en) * 2016-08-03 2019-09-10 Neil S. Davey Adjustable rate drug delivery implantable device
CN111989068A (zh) 2018-05-24 2020-11-24 塞拉尼斯伊娃高性能聚合物公司 用于持续释放大分子药物化合物的可植入器件
WO2019226516A1 (en) 2018-05-24 2019-11-28 Celanese EVA Performance Polymers Corporation Implantable device for sustained release of a macromolecular drug compound

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016251A (en) * 1972-08-17 1977-04-05 Alza Corporation Vaginal drug dispensing device
US4469671A (en) * 1983-02-22 1984-09-04 Eli Lilly And Company Contraceptive device
GB9326255D0 (en) * 1993-12-23 1994-02-23 Roussel Lab Ltd Medical device for the prevention and treatment of cancer
DE69616551T2 (de) * 1995-07-04 2002-05-29 Akzo Nobel Nv Ringförmige vorrichtung
US20040044080A1 (en) * 1997-10-28 2004-03-04 Place Virgil A. Treatment of dyspareunia with topically administered nitroglycerin formulations
WO2002076426A2 (en) * 2001-03-27 2002-10-03 Galen (Chemicals) Limited Intravaginal drug delivery devices for the administration of an antimicrobial agent
US6887270B2 (en) * 2002-02-08 2005-05-03 Boston Scientific Scimed, Inc. Implantable or insertable medical device resistant to microbial growth and biofilm formation
CA2496798A1 (en) * 2002-08-30 2004-03-11 Alza Corporation Embossable and writable multilaminate backing construction
WO2005070332A1 (en) * 2004-01-12 2005-08-04 The Trustees Of The University Of Pennsylvania Long-term delivery formulations and methods of use thereof
ES2327247T3 (es) * 2004-03-24 2009-10-27 N.V. Organon Sistema de administracion de farmacos basado en copolimeros de polietileno y acetato de vinilo.
US8173148B2 (en) * 2004-11-10 2012-05-08 Tolmar Therapeutics, Inc. Stabilized polymeric delivery system comprising a water-insoluble polymer and an organic liquid
JP2010510290A (ja) * 2006-11-22 2010-04-02 ナームローゼ・フエンノートチヤツプ・オルガノン ミルタザピンのための膣送達系
WO2008062008A1 (en) * 2006-11-22 2008-05-29 N.V. Organon Delivery system for a non-steroidal non-ionized hydrophilic drug

Also Published As

Publication number Publication date
CA2670454A1 (en) 2008-05-29
EP2094270A1 (en) 2009-09-02
CA2670157A1 (en) 2008-05-29
US20100203104A1 (en) 2010-08-12
WO2008062009A1 (en) 2008-05-29
WO2008062008A1 (en) 2008-05-29
JP2010510287A (ja) 2010-04-02
US20100104619A1 (en) 2010-04-29
JP2010510286A (ja) 2010-04-02
MX2009005444A (es) 2009-06-02
EP2094348A1 (en) 2009-09-02

Similar Documents

Publication Publication Date Title
MX2009005445A (es) Sistema de suministro para risperidona.
WO2008057867A3 (en) Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier
WO2010030728A3 (en) Devices and systems for delivery of therapeutic agents to body lumens
MX2009005446A (es) Sistema de suministro vaginal para mirtazapina.
WO2008100576A3 (en) Sustained delivery formulations of rapamycin compounds
WO2008148478A3 (de) Gastroretentives system mit alginat-körper
WO2011143500A3 (en) Self contained illuminated infusion cannula systems and devices
WO2011028846A3 (en) Cannula insertion device systems and methods
WO2008093851A1 (ja) 体腔用医療機器及びその製造方法
WO2013085901A3 (en) Systems and methods for delivery of a medical device
WO2012091748A3 (en) Therapeutic agent reservoir delivery system
WO2010035273A3 (en) Novel gastroretentive delivery system
WO2008063341A3 (en) Dual action, inhaled formulations providing both an immediate and sustained release profile
WO2006013374A3 (en) Polymeric medical devices for the control of microbial infections
WO2010019597A3 (en) Cyclo olefin polymer and copolymer medical devices
WO2010014690A3 (en) Medical devices for therapeutic agent delivery
WO2010062589A3 (en) Device for delivery of antimicrobial agent into trans-dermal catheter
WO2010088697A3 (en) Antimicrobial accessory for an implantable medical device
WO2008078318A3 (en) Systems and devices for sustained delivery of therapeutic fluid
WO2013009998A3 (en) Device for delivery of antimicrobial agent into trans-dermal catheter
WO2008002434A3 (en) Medical devices for release of low solubility therapeutic agents
WO2009105432A3 (en) Devices and methods for delivery of a therapeutic agent through a pneumostoma
WO2012017063A3 (en) Method and system for retaining a cartridge in a holder
WO2010103365A3 (en) Sustained release composition of therapeutic agent
WO2008136519A1 (ja) Ｅｐ４アゴニストを含有してなる細胞傷害性ｔ細胞の活性化剤

Legal Events

Date Code Title Description
HH Correction or change in general
FA Abandonment or withdrawal